Adam Thatcher is an associate in Goodwin’s Technology and Life Sciences groups, specialising in venture capital financings and M&A transactions. Mr. Thatcher advises clients on a broad range of corporate matters, with a particular focus on emerging growth companies and venture capital investors in the Fintech, life sciences, healthcare and technology sectors. Mr. Thatcher advises clients through every stage of the corporate life cycle.

Mr. Thatcher has been recognized for his venture capital and corporate work by the following industry publications:

  • Rising Star: Venture Capital in London, Legal 500 2020, 2021 and 2022
  • Rising Star: Corporate and Commercial in Cambridge, Legal 500 2020, 2021 and 2022
  • Recommended Individual: Corporate and Commercial, Legal 500 UK 2019

Mr. Thatcher has also been a speaker at various U.K. technology-focused accelerators and has written several articles and blog posts on financings.

Prior to joining Goodwin, Mr. Thatcher was a senior associate at Taylor Wessing LLP.

Areas of Practice
业务范围
Domaines D’Expertise
TÄTIGKEITSFELDER

Experience

工作经历

EXPÉRIENCE

ERFAHRUNG

Representative Matters

代表事项

REFERENZMANDATE

Venture Financings – Technology
  • Hopin, on its $450 million Series D funding round, led by Arena Holdings and Altimeter Capital, and its $400 million Series C funding round, led by Andreessen Horowitz and General Catalyst
  • Lead Investor, on its investment into Zepz (formerly WorldRemit Group) as part of a $292 million Series E funding round
  • Omnipresent, on its $120 million Series B funding round led by Kinnevik and Tencent
  • CIC, Arm and Avery Dennison, on their investment into PragmatIC Semiconductor as part of a $80 million Series C funding round
  • Zapp, on its $200 million Series B funding round co-led by Lightspeed468 Capital, and BroadLight Capital
  • Index Ventures, on its lead investment into Dream Games, as part of a $255 million Series C funding round
  • 7Bridges, on its $17 million Series A funding round led by Eight Roads
  • Recharge.com, on its $35 million Series B funding round led by SmartFin
  • Raspberry Pi, on its $45 million financing from Lansdowne Partners and Ezrah Charitable Trust
  • Tessian, on its $65 million Series C funding round led by March Capital
  • Vivid Money, on its $114 million Series C funding round led by Greenoaks Capital and its prior Series B funding round
  • Cutover, on its $35 million Series B funding round led by Eldridge
  • Streetbees, on its $40 million Series B funding round led by Lakestar
  • HM Treasury on the creation of the Future Fund, providing more than £1 billion of convertible loan financing to UK start-ups
  • Cleo on its $44 million Series B funding round led by EQT Ventures
  • Ribbit Capital, on its €15 million lead investment into Vivid Money
  • Index Ventures on its $10 million lead investment into Codat
  • CIC on its lead investment into AudioTelligence as part of a £6.5 million funding round
  • Citymapper on its Series B fundraising and its equity crowdfunding round
  • Tokamak Energy on its £35 million funding round*
  • MarketFinance on its £26 million funding round led by Barclays and Santander InnoVentures*
  • Second Home on its £20 million funding round*
  • Monzo, on its £113 million Series F funding round led by Y Combinator, having acted on all prior funding rounds*
  • Farfetch.com on its $397 million Series G funding round led by Chinese investor JD.com*
  • Onfido on its $50 million funding round led by SBI InvestmentSalesforce VenturesM12 and FinVC*
  • Gousto on its £30 million funding round led by Perwyn*
  • Olio on its £5 million funding round led by Octopus Ventures*
  • GV (formerly Google Ventures) on its lead investment into Scandit as part of a $30 million funding round*

*Denotes experience prior to joining Goodwin.

Venture Financings – Life Sciences
  • Morningside, on its lead investment into Ieso Digital Health as part of a $50 million Series B funding round
  • Closed Loop Medicine, on its £13 million Series A funding round, led by Ananda Impact Ventures and BGF
  • Novo Holdings on its lead investment into Exscientia as part of a $60 million Series C funding round and its follow-on investment as part of a $225 million Series D funding round
  • Endomag on its $20 million Series D funding round led by Draper Esprit 
  • Morningside on its lead investment into Immune Regulation, as part of a £25 million Series B funding round
  • Medicxi on its lead investment into Janpix, as part of a $10 million Series B funding round 
  • Evonetix on its £9 million funding round led by Morningside Ventures and Draper Esprit*
  • Temasek on its $90 million lead investment into BenevolentAI*

*Denotes experience prior to joining Goodwin.

Mergers and Acquisitions
  • The sale of Minesoft to MLM2 and Warburg Pincus
  • The sale of Breaking Free Online to Lifeworks Corporation
  • Hopin on various buy-side acquisitions
  • The sale of Magic Pony to Twitter for over £100 million*
  • The sale of Grapeshot to Oracle Corporation*
  • The sale of Sonalytic to Spotify*
  • The sale of Unruly to News Corporation for over £100 million*

*Denotes experience prior to joining Goodwin.

Recognition

  • Rising Star: Venture Capital in London, Legal 500 2020, 2021 and 2022
  • Rising Star: Corporate and Commercial in Cambridge, Legal 500 2020, 2021 and 2022
 

In The News

相关新闻

ACTUALITÉS

MELDUNGEN

Credentials

专业资格

RÉFÉRENCES

WERDEGANG

Education

Legal Practice Course, (Solicitor), 2012
Kaplan Law School
LL.B., (Bachelor of Laws), 2011
Durham University

Admissions

Bar

Solicitor of the Senior Courts of England and Wales
Profile Image
Get In Touch
联系我们
NOUS CONTACTER
Kontakt
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
搜寻其他律师
Recherche par Pratique
ANWALTSSUCHE